Ian F Pollack
Overview
Explore the profile of Ian F Pollack including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
286
Citations
9732
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xiong Z, Walsh K, Sneiderman C, Nisnboym M, Hadjipanayis C, Agnihotri S, et al.
Neuro Oncol
. 2025 Feb;
PMID: 39949048
Background: Individual-level characteristics underlying population-level variation in glioma risk and outcomes remain incompletely understood. Cancer immunosurveillance, host immunity, and some immunotherapies center on the ability of an individual's immune cells...
2.
Yengo-Kahn A, Wellons J, Jensen H, Kulkarni A, Chu J, Hauptman J, et al.
J Neurosurg Pediatr
. 2025 Feb;
:1-11.
PMID: 39919296
Objective: Conditional survival incorporates the effect of time passed since an event to current data in an easy-to-understand, relevant format. Data from the Hydrocephalus Clinical Research Network (HCRN) registry were...
3.
Isaacs A, Shannon C, Browd S, Hauptman J, Holubkov R, Jensen H, et al.
J Neurosurg Pediatr
. 2025 Jan;
:1-12.
PMID: 39889292
Objective: This study investigated neurodevelopmental outcomes in preterm neonates with posthemorrhagic hydrocephalus (PHH), focusing on the comparative effectiveness of temporary and permanent CSF diversion strategies. Methods: This multicenter prospective observational...
4.
Lee J, Tao R, You Z, Haldipur P, Erickson A, Farooq H, et al.
Nat Genet
. 2025 Jan;
57(1):88-102.
PMID: 39753768
Transcription factors are frequent cancer driver genes, exhibiting noted specificity based on the precise cell of origin. We demonstrate that ZIC1 exhibits loss-of-function (LOF) somatic events in group 4 (G4)...
5.
Bonfield C, Alexander A, Birgfeld C, Couture D, David L, French B, et al.
Neurosurg Focus
. 2025 Jan;
58(1):E3.
PMID: 39742514
Objective: Patients with a history of surgery for single-suture craniosynostosis (SSC) as an infant often wish to participate in sports later in childhood. However, there are no established guidelines from...
6.
Malhotra A, Kulkarni A, Verhey L, Reeder R, Riva-Cambrin J, Jensen H, et al.
Childs Nerv Syst
. 2024 Dec;
41(1):42.
PMID: 39658658
Purpose: This Hydrocephalus Clinical Research Network (HCRN) study had two aims: (1) to compare the predictive performance of the original ETV Success Score (ETVSS) using logistic regression modeling with other...
7.
Nisnboym M, Sneiderman C, Jaswal A, Xiong Z, Vincze S, Sever R, et al.
Expert Rev Clin Immunol
. 2024 Oct;
21(2):239-247.
PMID: 39402706
Background: Glioblastoma (GBM) is an aggressive cancer with limited treatment options. Immunotherapy targeting CD69, an early activation marker on T cells, has shown promise in preclinical models of non-CNS malignancies....
8.
Frederico S, Raphael I, Nisnboym M, Huq S, Schlegel B, Sneiderman C, et al.
Expert Rev Clin Immunol
. 2024 Aug;
20(11):1411-1420.
PMID: 39114885
Objectives: Despite surgical resection, chemoradiation, and targeted therapy, brain tumors remain a leading cause of cancer-related death in children. Immunotherapy has shown some promise and is actively being investigated for...
9.
Simon T, Rezvan P, Coffin S, Hall M, Hauptman J, Kronman M, et al.
J Neurosurg Pediatr
. 2024 Jul;
34(4):357-364.
PMID: 39029119
Objective: The Hydrocephalus Clinical Research Network (HCRN) implemented a perioperative infection prevention bundle for all CSF shunt surgeries in 2007 that included the relatively unproven technique of intrathecal instillation of...
10.
Ravindra V, Riva-Cambrin J, Jensen H, Whitehead W, Kulkarni A, Limbrick D, et al.
J Neurosurg Pediatr
. 2024 Jul;
34(4):305-314.
PMID: 38968629
Objective: When the peritoneal cavity cannot serve as the distal shunt terminus, nonperitoneal shunts, typically terminating in the atrium or pleural space, are used. The comparative effectiveness of these two...